Revolution Medicines, Inc. Common Stock (RVMD) is a publicly traded Healthcare sector company. As of August 19, 2026, RVMD trades at $217.06 with a market cap of $45.44B and a P/E ratio of -36.06. RVMD moved +1.88% today. Year to date, RVMD is +171.19%; over the trailing twelve months it is +492.59%. Its 52-week range spans $29.17 to $216.72. Analyst consensus is strong buy with an average price target of $220.48. Rallies surfaces RVMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RVMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RVMD recently traded at $217.06. Market cap is $45.44B. P/E ratio is -36.06. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $217.06 |
| Market Cap | $45.44B |
| P/E Ratio | -36.06 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $216.72 |
| 52-Week Low | $29.17 |
| Volume | 1.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-1.13B |
| Gross Margin | 0.00% |
19 analysts cover RVMD: 0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $220.48.